Key molecules for US market from torrent pharma in fy 16 would remain abilify and l detrol. Innovator had sales of 570 million USD and there seems to be limited competition for torrent in the molecule.
projections for the products based on a recent in depth research report are
abilify for fy 16 — 156 million USD and for fy 17 —20 million USD.
detrol for fy 16 — 49 million USD and for fy 17 —– 57 million USD.
nexium for fy 16 –11 million USD and for fy 17 —-45 million USD
minocycline at 20 million USD for both fy 16 and fy 17.
We will of course need the pharma enthusiasts in our group to verify these projections.
| Subscribe To Our Free Newsletter |
